WebFeb 2, 2024 · RVNC Bullish insiders at Revance Therapeutics, Inc. (NASDAQ:RVNC) loaded up on US$1.0m of stock earlier this year Contributor Simply Wall St Simply Wall St Published Feb 2, 2024 10:20AM EST... WebRevance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform.
RVNC Revance Therapeutics Inc. Profile MarketWatch
WebApr 10, 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Revance Therapeutics stock is Moderate Buy based on the current 2 hold ratings and 6 buy ratings for RVNC. The average twelve-month price prediction for Revance Therapeutics is $40.91 with a high price target of $65.00 and a low price target of $26.00. WebApr 11, 2024 · Inspire Investing LLC grew its stake in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC - Get Rating) by 66.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.The fund owned 12,798 shares of the biopharmaceutical company's stock after buying an additional 5,109 … middlesbrough swimming gala
Revance Therapeutics, Inc. (NASDAQ:RVNC) insiders placed …
WebApr 11, 2024 · Revance Therapeutics (RVNC) H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Revance Therapeutics today and set a price target of $42.00 . The company’s shares closed last Monday ... WebFeb 1, 2024 · Revance Therapeutics Stock Insider Trading. Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 41.080. In total, … WebThe 22 analysts offering price forecasts for Revance Therapeutics have a median target of 31.09, with a high estimate of 42.00 and a low estimate of 17.00. The median estimate … middlesbrough tees valley finder